Concepedia

Author

Nelusha Amaladas

Eli Lilly (United States)

Also Known As

Amaladas Nelusha, N. Amaladas, Nelusha Amaladas

24

Publications

620

Citations

6

H-Index

22

Concepts

All Affiliations

Eli Lilly (United States)
NA

About

Nelusha Amaladas is an author at Eli Lilly (United States) specializing in medicine, immunology, and tumor immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

44

2

Immunology

3

3

44

3

Cell Biology

2

2

26

4

Pathology

2

2

30

5

Cancer Cell Biology

1

1

12

Nelusha Amaladas

×

6

Publications

608

Citations

6

H-Index

YearCitations

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade

David Schaer, Richard P. Beckmann, Jack Dempsey,

Cell Reports

2018

418

The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy

David Schaer, Sandaruwan Geeganage, Nelusha Amaladas,

Clinical Cancer Research

2019

121

Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma

Ritu Chaudhary, Robbert J.C. Slebos, Feifei Song,

Molecular Carcinogenesis

2020

25

Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models

Yanxia Li, Nelusha Amaladas, Marguerita O’Mahony,

PLoS ONE

2022

18

Abstract 4549: Pemetrexed enhances anti-tumor efficacy of PD1 pathway blockade by promoting intra tumor immune response via immunogenic tumor cell death and T cell intrinsic mechanisms

Ruslan D. Novosiadly, David Schaer, Nelusha Amaladas,

Cancer Research

2018

14

Abstract 4835: LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions

David Surguladze, Anthony L. Pennello, Xiaodi Ren,

Cancer Research

2019

12

Page 1